Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Vaneckova

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
AJNR. American Journal of Neuroradiology|April 14, 2012
Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosisN Bergsland, D Horakova, M G Dwyer, et al.
AJNR. American Journal of Neuroradiology|March 2, 2019
A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MSR Zivadinov, D Horakova, N Bergsland, et al.
AJNR. American Journal of Neuroradiology|April 29, 2017
Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple SclerosisA Burgetova, P Dusek, M Vaneckova, et al.
European Journal of Neurology|April 24, 2015
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1aT Uher, D Horakova, T Kalincik, et al.
Genes and Immunity|April 12, 2013
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndromeT Kalincik, C R G Guttmann, J Krasensky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control studyD Horakova, J L Cox, E Havrdova, et al.
AJNR. American Journal of Neuroradiology|June 27, 2015
Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated SyndromeM Varosanec, T Uher, D Horakova, et al.
AJNR. American Journal of Neuroradiology|April 13, 2013
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 yearsR Zivadinov, N Bergsland, O Dolezal, et al.
European Journal of Neurology|November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approachT Uher, M Vaneckova, M P Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2009
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosisE Havrdova, R Zivadinov, J Krasensky, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
AJNR. American Journal of Neuroradiology|April 14, 2012
Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosisN Bergsland, D Horakova, M G Dwyer, et al.
AJNR. American Journal of Neuroradiology|March 2, 2019
A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MSR Zivadinov, D Horakova, N Bergsland, et al.
AJNR. American Journal of Neuroradiology|April 29, 2017
Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple SclerosisA Burgetova, P Dusek, M Vaneckova, et al.
European Journal of Neurology|April 24, 2015
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1aT Uher, D Horakova, T Kalincik, et al.
Genes and Immunity|April 12, 2013
Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndromeT Kalincik, C R G Guttmann, J Krasensky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control studyD Horakova, J L Cox, E Havrdova, et al.
AJNR. American Journal of Neuroradiology|June 27, 2015
Longitudinal Mixed-Effect Model Analysis of the Association between Global and Tissue-Specific Brain Atrophy and Lesion Accumulation in Patients with Clinically Isolated SyndromeM Varosanec, T Uher, D Horakova, et al.
AJNR. American Journal of Neuroradiology|April 13, 2013
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 yearsR Zivadinov, N Bergsland, O Dolezal, et al.
European Journal of Neurology|November 23, 2016
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approachT Uher, M Vaneckova, M P Sormani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2009
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosisE Havrdova, R Zivadinov, J Krasensky, et al.
Pageof 3